In contrast, while short-acting GLP-1 RAs did not show significant effects on MAKE in our cohort, it is important to note that lixisenatide has shown kidney benefits in the ELIXA trial 32
Ensure you are getting enough of these key nutrients: Protein: Hair is made of protein, so a sufficient intake is crucial
Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo controlled trial
More recently, in March 2024, Wegovy was This approval followed promising results from novo Nordisks SELECT trial, which followed 17,604 adults with obesity or overweight and cardiovascular disease but no history of diabetes
A 2020 preclinical toxicity review found no serious toxicity in mice, rats, rabbits, or dogs at tested doses, but longterm human carcinogenicity or organtoxicity data are missing
Lack of ongoing care Safe treatment requires follow-ups, dose adjustments, and side-effect monitoring